Asset Management One Co., Ltd. Bluebird Bio, Inc. Transaction History

Asset Management One Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $635,650 - $834,765	-13,536 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $197,639 - $274,177	2,606 Added 23.84%	13,536 $1.72 Million
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $37,764 - $59,593	639 Added 6.21%	10,930 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $277,243 - $366,568	3,120 Added 43.51%	10,291 $1.49 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $101,832 - $130,396	1,022 Added 16.62%	7,171 $1.11 Million
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $650,564 - $928,130	6,149 New	6,149 $1.05 Million

151

64.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27.8M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.